• Publications
  • Influence
Colchicine in Addition to Conventional Therapy for Acute Pericarditis: Results of the COlchicine for acute PEricarditis (COPE) Trial
Background—Colchicine is effective and safe for the treatment and prevention of recurrent pericarditis and might ultimately serve as the initial mode of treatment, especially in idiopathic cases. TheExpand
  • 384
  • 18
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on
In this paper the Working Group on Myocardial and Pericardial Disease proposes a revised definition of dilated cardiomyopathy (DCM) in an attempt to bridge the gap between our recent understanding ofExpand
  • 350
  • 15
  • PDF
Controversial Issues in the Management of Pericardial Diseases
The management of pericardial diseases is largely empirical because of the relative lack of randomized trials. The first published guidelines1,2 are a first attempt to organize current knowledge. AtExpand
  • 235
  • 13
  • PDF
Day-hospital treatment of acute pericarditis: a management program for outpatient therapy.
OBJECTIVES We sought to investigate the safety and efficacy of a protocol for acute pericarditis triage and outpatient management of low-risk cases. BACKGROUND Acute pericarditis has generally aExpand
  • 193
  • 10
Colchicine for Recurrent Pericarditis (CORP)
BACKGROUND Recurrence is the most common complication of pericarditis, affecting 10% to 50% of patients. OBJECTIVE To evaluate the efficacy and safety of colchicine for the secondary prevention ofExpand
  • 181
  • 10
  • PDF
Myopericarditis versus viral or idiopathic acute pericarditis
Objective: To investigate the relative incidence, clinical presentation and prognosis of myopericarditis among patients with idiopathic or viral acute pericarditis. Design: Prospective observationalExpand
  • 163
  • 10
Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial.
IMPORTANCE Postpericardiotomy syndrome, postoperative atrial fibrillation (AF), and postoperative effusions may be responsible for increased morbidity and health care costs after cardiac surgery.Expand
  • 176
  • 10
  • PDF
Management of pericardial effusion.
Pericardial effusion is a common finding in clinical practice either as incidental finding or manifestation of a systemic or cardiac disease. The spectrum of pericardial effusions ranges from mildExpand
  • 176
  • 10
  • PDF
A randomized trial of colchicine for acute pericarditis.
BACKGROUND Colchicine is effective for the treatment of recurrent pericarditis. However, conclusive data are lacking regarding the use of colchicine during a first attack of acute pericarditis and inExpand
  • 249
  • 9
  • PDF